09:18 AM EST, 12/17/2024 (MT Newswires) -- Natera ( NTRA ) said Tuesday that it has expanded its patent infringement lawsuit against NeoGenomics ( NEO ) related to the latter's modified version of RaDaR tests for molecular residual disease.

Natera ( NTRA ) said the District Court for the Middle District of North Carolina has granted its request to include an additional patent as part of the lawsuit.

Natera ( NTRA ) is asking the court to award it full remedies against NeoGenomics' ( NEO ) current RaDaR test offering, including injunctive relief.

NeoGenomics ( NEO ) did not immediately respond to a request for comment from MT Newswires.